Cell Communication: Studying gap junctions with PARIS

A new genetically encoded system manipulates the pH inside cells to detect whether they are coupled to each other.
  1. Daniel R Kick
  2. David J Schulz  Is a corresponding author
  1. University of Missouri-Columbia, United States

For our bodies to work properly, cells need to communicate with each other. One way to do so is via gap junctions, which are connections between cells that allow small signaling molecules or electrical signals to pass between them. Cells coupled together by gap junctions often synchronize their activity (Bennett and Zukin, 2004).

Neuromodulators and the activity of neurons can affect gap junction coupling between neurons, which, in turn, can influence the pattern of activity in neurons (Lane et al., 2018; Haas et al., 2011). Gap junctions have also been implicated in a variety of diseases (Nielsen et al., 2012). So far, it has been difficult to identify their precise roles in health and disease, as present methods to map or monitor gap junction coupling are often invasive and damaging, or unable to measure a specific cell type in enough detail.

Now, in eLife, Yulong Li and colleagues at Peking University – including Ling Wu as first author – report that they have developed a new method called PARIS to map and measure gap junctions (Wu et al., 2019). PARIS is a genetically encoded system, consisting of an optically controlled ‘actuator’ in one cell (the actuator cell) and a fluorescent sensor in another (the receiver cell). When stimulated with light, the actuator generates an electrochemical gradient with the help of a light-gated proton pump. The activated pump then transports hydrogen ions out of the cell. If the cells are coupled to each other, the departing ions change the pH in the receiver cell, causing a measurable increase in fluorescence (Figure 1A,B).

Detecting gap junction coupling.

(A) A new method called PARIS can be used to study gap junctions between cells (black squares). It is a genetically encoded system in which one cell (the ‘actuator’) contains a light-gated proton pump (ArchT). If the actuator cell is coupled to another (‘receiver’) cell, shining light onto the pump (blue trace) causes protons (H+, black circles) to flow, generating a measurable electrical current (black trace, pA). (B) In an alternate detection method, a fluorescent sensor (pHluorin, green oval) can be placed in the receiver cell. Once activated, the pump transports protons out of the actuator cell; if the cells are coupled, this induces a change in the pH of the receiver cell that increases the fluorescence of the sensor (green trace). (C) PARIS can be used to determine whether gap junction coupling (GJC) exists between different cell types by using light (blue beam) to stimulate a particular type of neuron and checking for fluorescence (green) from another type of neuron. For example, Wu et al. showed that excitatory projection neurons (ePN) in the Drosophila brain (black shape, left hemisphere) form gap junctions with excitatory local neurons (eLN) but not with other nearby cell types (KC, glia, iLN).

The pH gradient generated by PARIS can be detected in multiple receiver cells, even when they are not coupled directly to the actuator. Changes to the pH are known to affect the coupling and the strength of gap junctions (Nielsen et al., 2012). However, Wu et al. show that a slight pH increase of 0.1 is sufficient to detect gap junction coupling and therefore does not appear to disrupt the activity of a cell, even in repeated trials.

Furthermore, the change of fluorescence is noticeable within seconds and provides a consistent signal over repeated measurements that is strong enough to be tracked over hours. Moreover, since the technique is fully genetically encoded, there is no need to use dyes or to deliver compounds directly into the cell. Instead, Wu et al. have shown that PARIS can be delivered into the cell by various molecular gene transfer techniques, including virus-based transfer methods, allowing it to be applied to a wide range of organisms.

Given these attributes, PARIS can be used in a variety of fields where it promises to accelerate and expand research. For example, it could be used to study abnormal gap junction coupling associated with certain conditions, or to monitor drugs expected to alter coupling (Haas et al., 2011; Lane et al., 2018; Lane et al., 2016). It may even be used to study signaling within a cell, as it has been shown that certain intracellular enzymes can alter gap junction coupling too.

The ability of PARIS to assess gap junction coupling between individual cell types, especially in the brain, is particularly attractive. Wu et al. were able to confirm that in the olfactory system of fruit flies, a type of neuron known as an excitatory projection neuron, forms gap junctions with excitatory local neurons, but not with other nearby cell types (Figure 1C; Huang et al., 2010; Yaksi and Wilson, 2010).

PARIS also can be used to gain insight into where cells connect with each other. For example, the researchers revealed that excitatory and inhibitory projection neurons are coupled at their dendrites rather than at their axons. This degree of resolution is invaluable for studying nervous systems, and is difficult to achieve by other means.

Projects to map the brain connectivity in humans and other species based on chemical synaptic connectivity alone will be incomplete because they fail to describe alternate pathways information may use to travel, such as gap junctions (Marder et al., 2017). With future improvements in the sensitivity of the fluorescent receiver to an even smaller pH change, PARIS has the potential to be a valuable tool to study cell communication and its role in many different diseases.

References

Article and author information

Author details

  1. Daniel R Kick

    Daniel R Kick is in the Division of Biological Sciences, University of Missouri-Columbia, Columbia, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9002-1862
  2. David J Schulz

    David J Schulz is in the Division of Biological Sciences, University of Missouri-Columbia, Columbia, United States

    For correspondence
    SchulzD@missouri.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4532-5362

Publication history

  1. Version of Record published: March 1, 2019 (version 1)

Copyright

© 2019, Kick and Schulz

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,121
    Page views
  • 135
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Daniel R Kick
  2. David J Schulz
(2019)
Cell Communication: Studying gap junctions with PARIS
eLife 8:e45207.
https://doi.org/10.7554/eLife.45207

Further reading

    1. Neuroscience
    Chandima Bulumulla et al.
    Research Article

    Chemical neurotransmission constitutes one of the fundamental modalities of communication between neurons. Monitoring release of these chemicals has traditionally been difficult to carry out at spatial and temporal scales relevant to neuron function. To understand chemical neurotransmission more fully, we need to improve the spatial and temporal resolutions of measurements for neurotransmitter release. To address this, we engineered a chemi-sensitive, two-dimensional composite nanofilm that facilitates visualization of the release and diffusion of the neurochemical dopamine with synaptic resolution, quantal sensitivity, and simultaneously from hundreds of release sites. Using this technology, we were able to monitor the spatiotemporal dynamics of dopamine release in dendritic processes, a poorly understood phenomenon. We found that dopamine release is broadcast from a subset of dendritic processes as hotspots that have a mean spatial spread of 3.2 µm (full width at half maximum) and are observed with a mean spatial frequency of 1 hotspot per 7.5 µm of dendritic length. Major dendrites of dopamine neurons and fine dendritic processes, as well as dendritic arbors and dendrites with no apparent varicose morphology participated in dopamine release. Remarkably, these release hotspots colocalized with Bassoon, suggesting that Bassoon may contribute to organizing active zones in dendrites, similar to its role in axon terminals.

    1. Neuroscience
    Jonathan S Schor et al.
    Research Article

    Subthalamic nucleus deep brain stimulation (STN DBS) relieves many motor symptoms of Parkinson's Disease (PD), but its underlying therapeutic mechanisms remain unclear. Since its advent, three major theories have been proposed: (1) DBS inhibits the STN and basal ganglia output; (2) DBS antidromically activates motor cortex; and (3) DBS disrupts firing dynamics within the STN. Previously, stimulation-related electrical artifacts limited mechanistic investigations using electrophysiology. We used electrical artifact-free GCaMP fiber photometry to investigate activity in basal ganglia nuclei during STN DBS in parkinsonian mice. To test whether the observed changes in activity were sufficient to relieve motor symptoms, we then combined electrophysiological recording with targeted optical DBS protocols. Our findings suggest that STN DBS exerts its therapeutic effect through the disruption of movement-related STN activity, rather than inhibition or antidromic activation. These results provide insight into optimizing PD treatments and establish an approach for investigating DBS in other neuropsychiatric conditions.